early outcome of concurrent mitral valve replacement and coronary artery bypass grafting
Authors
abstract
concomitant coronary artery bypass surgery (cabg) in patients undergoing mitral valve replacement (mvr) has been shown to be an important risk factor for hospital mortality. we evaluated preoperative characteristics, postoperative complications, in-hospital mortality rate, and length of stay in hospital for patients undergoing concurrent cabg with mvr. preoperative and postoperative clinical data from 175 patients undergoing concurrent cabg with mvr operation at tehran heart center from 2002 through 2006 were collected and entered into a database. information was obtained by clinical and case note review as well as detailed questionnaires to physicians and patients. mean age of patients was 57.95 ± 10.54 years and 51.4% were male. mean new york heart association (nyha) score was 2.46 ± 0.84. among studied patients, 18.3% and 2.9% underwent aortic and tricuspid valve replacement, respectively. in-hospital mortality was 6.9% and 96.0% of patients were hospitalized ≥14 days. history of congestive heart failure (p = 0.027) and postoperative brain stroke (p = 0.004) were independent predictors for in-hospital mortality. exact considering of congestive heart failure and postoperative brain stroke related to in-hospital mortality in concurrent cabg with mvr operation are necessary.
similar resources
High-risk Coronary Artery Bypass Grafting and Mitral Valve Replacement in a HIV Positive Patient
Certain subsets of high-risk mitral valve patients are not suitable candidates for transcatheter therapies. The objective of this report is to present a young patient with combined mitral valve and coronary artery disease to illustrate these challenges.In this report, we present a 47-year-old man with longstanding HIV infection who was referred with severe mitral regurgitation (MR) and profound...
full textHigh-risk Coronary Artery Bypass Grafting and Mitral Valve Replacement in a HIV Positive Patient
Article type: Case report Certain subsets of high-risk mitral valve patients are not suitable candidates for transcatheter therapies. The objective of this report is to present a young patient with combined mitral valve and coronary artery disease to illustrate these challenges.In this report, we present a 47-yearold man with longstanding HIV infection who was referred with severe mitral regurg...
full textOutcome of total arch replacement with coronary artery bypass grafting.
OBJECTIVES There are few reports on the outcome of total arch replacement (TAR) with concomitant coronary artery bypass grafting (CABG); the present study was aimed at analysing outcomes after TAR with CABG at our institute. METHODS Between January 2002 and December 2012, 123 consecutive patients underwent elective TAR with or without CABG. The patients were divided into two groups: 46 who ha...
full textMitral valve replacement or repair after previous coronary artery bypass grafting.
BACKGROUND Patients who have had previous CABG may subsequently develop significant mitral valve (MV) dysfunction that requires surgical intervention. METHODS AND RESULTS We reviewed 80 consecutive patients who had had previous CABG and who underwent MV surgery between January 1972 and March 1997. Forty-seven (59%) had initial CABG elsewhere, and 5 had had previous CABG twice. The mean interv...
full textConsequences of coronary artery bypass grafting in smokers and addicts
Introduction: The most common cardiac disease is coronary artery disease (CAD) in the world. Coronary artery bypass grafting (CABG) is implemented through two standard surgical techniques, namely off-pump beating-heart CABG (OPCABG) and on-pump CABG (ONCABG). The CABG results in various levels of morbidity, especially in smokers and addicts, who have a lower pain threshold. Regarding this, the ...
full textMitral valve repair for ischemic moderate mitral regurgitation in patients undergoing coronary artery bypass grafting
OBJECTIVES To investigate whether mitral valve repair (MVR) at the time of coronary artery bypass grafting (CABG) in patients with ischemic moderate mitral regurgitation (MR) and coronary artery disease could improve short- and mid-term postoperative outcomes. METHODS Between March 2013 and December 2015, 90 patients with moderate ischemic MR underwent first-time CABG in Bursa Yuksek Ihtisas...
full textMy Resources
Save resource for easier access later
Journal title:
acta medica iranicaجلد ۴۶، شماره ۳، صفحات ۲۱۳-۲۱۷
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023